X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Sterling Biotech with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STERLING BIOTECH vs TEVA PHARMA (Israel) - Comparison Results

STERLING BIOTECH    Change

Sterling Biotech primarily produces and distributes pharmaceutical grade gelatine globally. The company currently has a 7.5% share of the global market for pharmaceutical and nutraceutical gelatines. It has more than 70% market share in India. Sterli... More

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 STERLING BIOTECH   TEVA PHARMA
EQUITY SHARE DATA
    STERLING BIOTECH
Dec-13
TEVA PHARMA
Dec-13
STERLING BIOTECH/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs112,873-   
Low Rs32,496-   
Sales per share (Unadj.) Rs26.81,648.8-  
Earnings per share (Unadj.) Rs-15.0103.0-  
Cash flow per share (Unadj.) Rs-5.5236.3-  
Dividends per share (Unadj.) Rs090.17-  
Dividend yield (eoy) %03.4 0.0%  
Book value per share (Unadj.) Rs54.91,831.5-  
Shares outstanding (eoy) m267.87848.00-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.31.6 15.9%   
Avg P/E ratio x-0.526.1 -1.8%  
P/CF ratio (eoy) x-1.311.4 -11.2%  
Price / Book Value ratio x0.11.5 8.6%  
Dividend payout %087.5 0.0%   
Avg Mkt Cap Rs m1,8622,276,346 0.1%   
No. of employees `0001.444.9 3.0%   
Total wages/salary Rs m5470-   
Avg. sales/employee Rs Th5,303.331,109.4 17.0%   
Avg. wages/employee Rs Th403.80-   
Avg. net profit/employee Rs Th-2,959.01,943.4 -152.3%   
INCOME DATA
Net Sales Rs m7,1811,398,213 0.5%  
Other income Rs m430-   
Total revenues Rs m7,2231,398,213 0.5%   
Gross profit Rs m947382,901 0.2%  
Depreciation Rs m2,543113,019 2.3%   
Interest Rs m4,37727,463 15.9%   
Profit before tax Rs m-5,931242,419 -2.4%   
Minority Interest Rs m01,101 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-159,135 0.0%   
Tax Rs m-1,924-2,960 65.0%   
Profit after tax Rs m-4,00787,345 -4.6%  
Gross profit margin %13.227.4 48.2%  
Effective tax rate %32.4-1.2 -2,657.5%   
Net profit margin %-55.86.2 -893.2%  
BALANCE SHEET DATA
Current assets Rs m14,335944,348 1.5%   
Current liabilities Rs m49,809823,551 6.0%   
Net working cap to sales %-494.08.6 -5,718.3%  
Current ratio x0.31.1 25.1%  
Inventory Days Days40391 444.3%  
Debtors Days Days17196 177.9%  
Net fixed assets Rs m55,432456,687 12.1%   
Share capital Rs m2683,442 7.8%   
"Free" reserves Rs m13,9350-   
Net worth Rs m14,7011,553,149 0.9%   
Long term debt Rs m9,478714,937 1.3%   
Total assets Rs m73,9883,195,364 2.3%  
Interest coverage x-0.49.8 -3.6%   
Debt to equity ratio x0.60.5 140.1%  
Sales to assets ratio x0.10.4 22.2%   
Return on assets %0.53.6 13.9%  
Return on equity %-27.35.6 -484.6%  
Return on capital %-6.44.9 -130.3%  
Exports to sales %25.90-   
Imports to sales %0.20-   
Net fx Rs m1,8350-   
CASH FLOW
From Operations Rs m1,719222,803 0.8%  
From Investments Rs m-3,148-78,948 4.0%  
From Financial Activity Rs m1,426-267,267 -0.5%  
Net Cashflow Rs m-3-123,412 0.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 68.83 Rs / USD

Compare STERLING BIOTECH With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  

Compare STERLING BIOTECH With: GSK PHARMA  FRESENIUS KABI ONCO.  ALKEM LABORATORIES  FDC LTD.  LUPIN  



Today's Market

Sensex Ends 425 Points Higher; Banking and Energy Stocks Witness Buying(Closing)

Indian share markets witnessed buying interest during closing hours and ended their day on a positive note. Gains were largely seen in the banking sector and energy sector.

Related Views On News

Galaxy Surfactants Ltd. (IPO)

Jan 27, 2018

Should you subscribe to the IPO of Galaxy Surfactants Ltd?

More Views on News

Most Popular

My Top 3 Defence Stocks to Buy Now(The 5 Minute Wrapup)

Mar 19, 2019

The urgency to privatise India's defence sector to make India self-reliant was never as strong as it is today.

This Small Cap Stock Could Offer Triple Digit Gains from its Current Price(Profit Hunter)

Mar 19, 2019

If you are still waiting for signals, remember, there is no correct timing, only right time to Buy stocks. For select small caps, that time is now.

5 Fundamentally Strong Stocks to Pick for Trading Today(Profit Hunter)

Mar 15, 2019

5 fundamentally strong stocks one could buy to trade in this market right now. Make sure you grab the chance this strongly rallying market offers.

Elections Don't Matter!(The Honest Truth)

Mar 13, 2019

Ajit Dayal shows us why from the point of view of the Indian economy, elections don't matter.

Two Growth Stocks that Doubled in a Little Over 12 Months!(The 5 Minute Wrapup)

Mar 13, 2019

The elements that fueled profit growth for these two companies led to a surge in their stock prices.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

STERLING BIOTECH SHARE PRICE


Nov 5, 2018 (Close)

TRACK STERLING BIOTECH

  • Track your investment in STERLING BIOTECH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON STERLING BIOTECH

STERLING BIOTECH - TORRENT PHARMA COMPARISON

COMPARE STERLING BIOTECH WITH

MARKET STATS